Tibetan pig frozen semen detection reagent and application thereof

Through the specific monoclonal antibody PR31 and ELISA detection kit, the problem of low detection efficiency of pseudorabies virus in Tibetan pig semen was solved, and high sensitivity and specificity were achieved, meeting the needs of the breeding farm for detection.

CN118909103AInactive Publication Date: 2024-11-08BEIJING TYAR BIOLOGIC TECH CO LTD +1

Patent Information

Application Number
CN202411152523.8
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-21
Publication Date
2024-11-08
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

The existing detection methods cannot efficiently and accurately detect pseudorabies virus from Tibetan pig semen, and the traditional methods are cumbersome and inefficient, making it difficult to meet the needs of rapid detection in the farm.

Method used

A monoclonal antibody PR31 that specifically recognizes pseudorabies virus was developed, and combined with the ELISA detection kit, it was coated with enzyme label plate, blocking solution, sperm washing solution, enzyme label secondary antibody, washing solution, color developer and termination. Components such as liquids can achieve fast and simple detection.

Benefits of technology

It realizes high sensitivity and specificity detection of pseudorabies virus in Tibetan pig semen, can quickly process large batches of samples, and is easy to operate, avoiding the problems of low efficiency and large errors in existing methods, becoming the first domestically capable of accurate and rapid detection. kit.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118909103A_ABST
    Figure CN118909103A_ABST
Patent Text Reader

Abstract

The invention provides a detection antibody and a detection reagent for porcine pseudorabies virus in Tibetan pig semen and application of the detection antibody and the detection reagent. The monoclonal antibody can specifically recognize the pseudorabies virus in the Tibetan pig semen. The fluorescence detection test strip containing the antibody and the detection method thereof are simple and convenient to operate, can rapidly detect a large number of samples at the same time, and have the characteristics of high sensitivity and high specificity; and the kit is the first kit capable of accurately and rapidly detecting the pseudorabies virus in a Tibetan pig semen sample in China and even in the world at present.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the field of biotechnology, and in particular relates to a detection antibody and a detection reagent for pseudorabies virus in Tibetan pig semen and applications thereof. Background Art

[0002] Tibetan pigs are raised in high altitude areas such as Tibet in my country. They have the advantages of being able to adapt to the cold and hypoxic climate of the plateau and having good meat quality. They are grazing pigs that can adapt to the low oxygen and cold climate of the plateau and extensive feeding and management conditions. They have the characteristics of small litters, slow growth, and good meat quality. The crude protein content, unsaturated fatty acid content and essential fatty acid content in the muscle are high. They are a kind of health meat that meets the needs of modern consumption. Linzhi, Milin, Gongbujiangda and other areas with an average altitude of 2,900m are the main activity centers of Tibetan pigs. In order to reduce the cost of pig farming, the excellent genetic resources of Tibetan pigs in terms of disease resistance and adaptability can be used to improve the genetic structure of foreign pigs and pigs from other places.

[0003] In high-altitude areas, Tibetan pigs are less intensive and large-scale, and are mostly raised by grazing. In order to meet the huge demand for Tibetan pork from consumers and the requirements for safe and rapid propagation technology in newly built intensive Tibetan pig farms, the preservation technology and transportation of Tibetan pig semen are receiving more and more attention. However, more and more studies have found that many highly pathogenic viruses can infect sows and offspring through semen. Early studies have found that the main viruses present in Tibetan pig semen include pseudorabies virus, porcine reproductive and respiratory syndrome virus, porcine circovirus, etc. These viruses can cause sows to abort, produce mummies or stillbirths, and in severe cases cause large-scale deaths of pigs. Among them, pseudorabies is an acute, contact infectious disease caused by pseudorabies virus (PRV). PRV infection can cause a serious decline in the growth and reproduction indicators of pigs. my country has listed pseudorabies in pigs as a disease that needs to be purified. However, in recent years, studies have found that wild PRV strains have undergone new mutations (PRV II) and are more virulent than the classic strain (PRV I), and existing vaccines are difficult to provide effective protection. At present, there are clinical cases of human infection with PRV at home and abroad, mainly manifested as retinitis or endophthalmitis, and in severe cases, acute encephalitis may occur, and even develop into neurological symptoms.

[0004] Therefore, the purification of Tibetan pig semen can not only improve the utilization rate of excellent Tibetan pig boars, improve the conception rate and litter size of sows, but also reduce the number of breeding boars, so as to achieve the purpose of reducing production costs. At the same time, it can also avoid the spread of diseases through mating, thereby improving the economic benefits of pig production. There are research reports on the use of PCR methods to detect PRV from pig semen at home and abroad. The extraction of viral nucleic acid mainly refers to the processing method of conventional clinical samples, but these methods are not efficient in extraction and purification, cumbersome in operation, and time-consuming. At present, there is a lack of standardized methods and mature commercial kit methods for efficient detection of major pathogens from semen at home and abroad. Moreover, since the traditional detection methods are often targeted at serum samples, but there are many differences in protein, composition, pH, etc. between semen samples and semen samples, the effect in actual detection is not ideal and not targeted. Summary of the invention

[0005] In order to solve the above technical problems, the present invention provides a detection reagent for rapidly detecting pseudorabies virus in Tibetan pig semen.

[0006] Based on this, the present application provides a detection kit and a detection method thereof that can quickly and accurately detect pseudorabies virus in Tibetan pig semen samples, which has the characteristics of simple operation, ability to quickly detect a large number of samples at the same time, high sensitivity and high specificity.

[0007] To achieve the above objectives, the present invention first provides a monoclonal antibody PR31 that specifically recognizes pseudorabies virus. The monoclonal antibody can specifically recognize pseudorabies virus in Tibetan pig semen and is expected to be used for semen purification.

[0008] Furthermore, the amino acid sequence of the heavy chain variable region of the monoclonal antibody PR31 that specifically recognizes pseudorabies virus is shown in SEQ ID NO: 1 in the sequence listing, and the amino acid sequence of the light chain variable region is shown in SEQ ID NO: 2 in the sequence listing.

[0009] The specific sequence is:

[0010] Heavy chain variable region amino acid sequence

[0011] EVQLVESGPGAELMKPEGSLLRLSCAFSGFTFSDWIEWWWIRQTPKKEIFPGSNWIRGGTYTYYPDGLQGGISSNTV RAKNSLYLNSSEDSAVYYCARQEHDFPLFDYAQGTSVLTVSS(SEQ ID NO.4)

[0012] Light chain variable region amino acid sequence

[0013] DIVVMTQQKFMSASTVVGETCKARQDVGTAVTWYYNQQKQGFESVIYRSSTRHTGVPIYWASRFSGSSGTDFTLTT DSLQTLTIEDLADYFCQQYGYSSWGAGGGAGTKLVLK(SEQ ID NO.5)

[0014] Furthermore, the antibody may be modified with a label; the label is preferably an enzyme, a fluorescein, a chemiluminescent substance or fluorescence;

[0015] The above-mentioned monoclonal antibody obtained in the present application is obtained by using the full length of the pseudorabies virus glycoprotein gene (gE) as an immunogen, and is obtained by screening a classic hybridoma cell line. It has the characteristics of a simple immunogen preparation method and the ability of the obtained antibody to recognize natural proteins. The monoclonal antibody can recognize pseudorabies virus, and the reaction titer is higher than 819200. Moreover, since the existing recommended PRV vaccine in my country is a PRV glycoprotein gene (gE) deleted vaccine, the detection method provided in the present application can effectively avoid vaccine interference.

[0016] Furthermore, the present invention also provides a product for detecting pseudorabies virus in a sample, the product comprising the above-mentioned monoclonal antibody, and preferably, the sample is a Tibetan pig semen sample.

[0017] Furthermore, the product is an ELISA test kit, which includes a coated ELISA plate, a blocking solution, a sperm washing solution, an enzyme-labeled secondary antibody, a washing solution, a color developer, and a stop solution, wherein:

[0018] Coating ELISA plate: Dilute PRV-gE protein to a concentration of 0.5 μg / mL with CBS buffer (0.05M carbonate-bicarbonate buffer, pH 9.6), take 100 μL to coat 96-well ELISA plate, and coat overnight at 4°C. Take out the next day and wash the plate 3 times with PBST, 3 minutes each time. Use 1% BSA prepared with PBST solution as blocking solution, add 100 μL of blocking solution to each well, and block at 37°C for 1 hour. After blocking, wash the plate 3 times with PBST, 3 minutes each time. Put it into a special packaging bag for 96-well ELISA plate, seal it with a sealing machine, and store it at 4°C.

[0019] Enzyme-labeled secondary antibodies were purchased from Beijing Solebao Technology Co., Ltd.

[0020] Sperm washing solution: based on 1L system, Tris 25-35g, citric acid 8-11g, glucose 8-15g, cysteine ​​3-8mM;

[0021] Washing solution (25×PBST): NaCl 100.0 g, KCl 0.2 g, MgCl2·6H2O 2.5 g, KH2PO4 5.0 g, Na2HPO4 28.5 g, Tween-20 12.5 mL, thimerosal 2.5 g, dilute to 1000 mL with distilled water, add 0.02% sodium azide as a preservative, sterilize and filter, then dispense;

[0022] Blocking solution (1% BSA): 1.0 g bovine serum albumin dissolved in 100 mL washing solution;

[0023] TMB colorimetric solution;

[0024] Stop solution: Take 54.3mL of 95% concentrated sulfuric acid and add distilled water to 1000mL;

[0025] Positive control: Tibetan pig PRV positive serum;

[0026] Negative control: Weigh an appropriate amount of BSA into PBS solution to a concentration of 2 μg / mL, add 1000 IU of penicillin and streptomycin per mL, sterilize and filter, and make into powder as a positive control.

[0027] Beneficial Effects

[0028] The monoclonal antibody PR31 for specific identification of pseudorabies virus provided by the present invention can specifically identify pseudorabies virus in Tibetan pig semen. The fluorescent test strip containing the antibody and the detection method thereof are easy to operate, can quickly detect a large number of samples at the same time, and have the characteristics of high sensitivity and high specificity; it is also the first test kit in China and even in the world that can accurately and quickly detect pseudorabies virus in Tibetan pig semen samples. BRIEF DESCRIPTION OF THE DRAWINGS

[0029] Figure 1 PCR amplification of PRV gE protein, where M is a marker and 1 is a PRV gE protein fragment;

[0030] Figure 2 Western Blot was used to detect the expression of PRV gE protein, where M is a marker and 1 is HEK293T / 17 cells transfected with pcDNA3.0-PRV-gE.

[0031] Figure 3 Specific identification of monoclonal antibody PR31, where M is a marker, 1 is a blank HEK293T / 17 cell, and 2 is a HEK293T / 17 cell transfected with pcDNA3.0-PRV-gE. Example

[0032] The present invention is described in detail below in conjunction with specific drawings and embodiments. The examples described below are only preferred embodiments of the present invention. It should be noted that the following description is only for the purpose of explaining the present invention and does not limit the present invention in any form. Any simple modification, equivalent changes and modifications made to the embodiments according to the technical essence of the present invention are within the scope of the technical solution of the present invention.

[0033] In the following examples, the materials, plasmids, reagents, etc. used were obtained from commercial sources unless otherwise specified. Example 1 Screening and preparation of monoclonal antibodies specific for gE protein of PRV

[0034] According to early research results, the most prevalent PRV strain in Tibetan pigs was used as a template, and primers PRV-gE-F / R were designed according to gE and vector pCDNA3.0, and tag HA sequence (Beijing Huayueyang VECT90227) and synthesized by BGI Biotechnology Co., Ltd. The gE gene was cloned by polymerase chain reaction.

[0035] PRV-gE-F: CCCAAGCTTatgcggtccttctgctgcgcgccgcgcaccttctggcgctg (SEQ IDNO.1);

[0036] PRV-gE-R: CGGAATTCtcaagggtagtctgggacgtcgtatgggtacgcggggcgggacttcaacag (SEQ ID NO. 2).

[0037] After amplification, double enzyme digestion was performed and inserted into the expression vector pcDNA3.0 for screening and identification ( Figure 1The fragment with the correct size was selected for sequencing, and it was confirmed that the expressed protein was the gE protein of PRV (MRPFLLRAAQLLALLALALSTEAPSLSAETTPGPVTEVPSPSAEVWDDLSTEADDADLNG DLDGDDRRAGFGSALASLREAPPAHLVNVSEGANFTLDARGDGAVLAGIWTFLPVRGCDAVSVTTVCFETACHPDLVLGRACVPEAPEMGIGDYLPPEVPRLRREPPIVTPERWSPHLSVLRATPNDTGLYTLHDASGPRAVFFVSVGDRPPAPADPVGPARHEPRFHALGFHSQLFSPGDTFDLMPRVVSDMGDSRENFTATLDWYYARAPPRCLLYYVYEPCIYHPRAPECLRPVDPACSFTSPARARLVARRAYASCS PLLGDRWLTACPFDAFGEEVHTNATADESGLYVLVMTHNGHVATWDYTLVATAAEYVTVIKELTAPARAPGTPWGPGGGDDAIYVDGVTTPAPPARPWNPYGRTTPGRLFVLALGSFVMTCVVGGAIWLCVLCSRRRAASRPFRVPTRLRTHMLSPVYTSLPTHEDYYDGDDDADEEAGVIRRRPASPSGDSGYEGPYASLDPEDEFSSDEDDGLYVRPEEAPRSGFDVWFRDPEKPEVTNGPNYGVTANRLLMSRPA, SEQ ID NO.3). After selecting the positive plasmid pcDNA3.0-PRV-gE that correctly expresses the gE protein of PRV, it was transfected into HEK293T / 17 cells, and the cell protein was collected 24 hours after transfection. The target protein was recovered by SDS-PAGE gel ( Figure 2 ).

[0038] The purified PRV gE protein was used as an immunogen, mixed with an equal volume of adjuvant Quick Antibody-Mouse 5W, and then 6-8 week-old female BALB / c mice were selected for primary immunization. Immunization method: leg muscle injection; dose: 100nL / mouse. Reinforced immunization: 21 days after the first immunization, the second immunization was carried out, and the immunization route and dose were the same as the first. 14 days after the second immunization, the tail vein blood of the mice was collected, and the serum antibody level of the immunized mice was detected by indirect ELISA method. Mice with higher antibody levels were intraperitoneally injected with inactivated virus (100μL / mouse) for shock immunization.

[0039] 3-4 days after the injection, spleen cells were taken and fused with Sp2 / 0-AG14 cells. Female BALB / c mice aged 6-8 weeks were taken and killed by cervical dislocation. The abdominal cavity was flushed several times with incomplete RPMI 1640 medium under sterile conditions. The flushing fluid was centrifuged at 1000 rpm for 10 minutes and the supernatant was discarded. The cells were resuspended with complete RPMI 1640 medium and the cells were counted. The cell concentration was adjusted to 2×10 5 / mL, added into 96-well plate, 100 μL / well, and incubated in a 37°C, 5% CO2 incubator.

[0040] Take mice 3-4 days after immunization, bleed their eyeballs, and collect pre-fusion serum. Kill the mice by cervical incision, remove the spleen aseptically, prepare a single cell suspension, mix the spleen cells with Sp2 / 0-AG14 cells in the logarithmic growth phase at a ratio of 4:1, centrifuge at 1000rpm for 10min, and discard the supernatant. Resuspend the cells with 40-60mL of complete RPMI 1640 medium and inoculate them into a 96-well plate containing feeder cells, 100μL / well. Add 50μL of 5×HAT to each well on the second day. Incubate in a 37°C, 5% CO2 incubator and observe the cell growth status day by day. On the 5th day after the fusion is completed, use 1×HAT to replace the cell medium, and on the 14th day, replace it with 1×HT to replace the cell medium.

[0041] When the cell clones grow to 1 / 3 of the visual field, carefully aspirate the cell supernatant, use 400ng / mL PRV gE protein as the coating antigen, and detect the antibodies in the supernatant by indirect ELISA. Use the limiting dilution method to repeatedly clone the wells with positive antibody secretion until the antibody positive rate of all monoclonal wells is 100%.

[0042] The cloned positive clones were transferred into 24-well plates, 6-well plates and T25 cell culture flasks in sequence, and stably cultured for 90 days to establish strains.

[0043] Inoculate hybridoma cells into the peritoneal cavity of BABL / c mice pretreated with pristane and adjust the cell density to 1-2×10 7 Each mouse was injected with 500 μL of cell suspension. After 7 to 10 days, ascites was extracted and monoclonal antibody PR31 was purified by Protein A affinity chromatography using AKTAexplore100 protein purification system.

[0044] The monoclonal antibody PR31 obtained by screening was used to detect the eukaryotic expressed PRV-gE protein. HEK293T / 17 cells transfected with pcDNA3.0-PRV-gE were collected, the supernatant was discarded after centrifugation, PBS and 5× protein loading buffer were added to prepare protein samples, and SDS-PAGE electrophoresis was performed. The PR31 monoclonal antibody was diluted 1:100 as the primary antibody for Western Blot experiments. The results showed that the prepared monoclonal antibody PR31 recognized the PRV-gE sample, and a more obvious specific band ( Figure 3 ), but not with blank HEK293T / 17 cell protein. The results showed that the prepared PRV-gE monoclonal antibody could specifically bind to PRV-gE protein, indicating that the prepared PRV-gE monoclonal antibody PR31 has good reactivity and specificity.

[0045] The titer of the monoclonal antibody was determined by indirect ELISA, with PRV-gE protein as the coating antigen at a concentration of 0.5 μg / mL, 100 μL / well, and overnight coating at 4°C; the plate was washed 3 times with PBST; 5% skim milk powder was added for blocking, 200 μL / well, incubated at 37°C for 2 hours, and the plate was washed 3 times with PBST; 100 μL of the sample to be tested in a multiple dilution (the diluent was 0.01M PBS pH7.2) was added, incubated at 37°C for 1 hour, and the plate was washed 3 times with PBST; 100 μL / well of HRP-labeled goat anti-mouse IgG diluted 1:10000 (the diluent was 0.01M PBS pH7.2) was added, incubated at 37°C for 40 minutes, and the plate was washed 5 times with PBST; 100 μL / well of substrate solution was added, and color was developed at 37°C in the dark for 10-15 minutes, and 100 μL / well of stop solution was added. The OD450 value of each well was read and judged according to the ratio of positive antibody to negative antibody (P / N) greater than 2. The results showed that the titer of the monoclonal antibody could reach 1:819200.

[0046] Hybridoma cells in the logarithmic growth phase were taken, and the total RNA of the hybridoma cell line was extracted using the Trizol reagent method, and 1% agarose gel electrophoresis was performed. The heavy chain variable region gene and the light chain variable region gene of the anti-PRV gE protein monoclonal antibody gene were amplified by the RT-PCR method. Primers were designed according to the conserved sequences of the light chain and heavy chain of mouse IgG, respectively. According to the instructions of the GoldScript cDNA synthesis kit, total RNA was used as a template, and the first chain of cDNA was synthesized using Oligo(d)T primer and SuperScripII reverse transcriptase. After recovery and purification using a PCR product recovery kit (Omega Company), it was sent to Shanghai Sangon Biotechnology Company for sequencing analysis.

[0047] The amino acid sequence of the heavy chain variable region of monoclonal antibody PR31 is:

[0048] EVQLVESGPGAELMKPEGSLLRLSCAFSGFTFSDWIEWWWIRQTPKKEIFPGSNWIRGGTYTYYPDGLQGGISSNTV RAKNSLYLNSSEDSAVYYCARQEHDFPLFDYAQGTSVLTVSS(SEQ ID NO.4)

[0049] Light chain variable region amino acid sequence

[0050] DIVVMTQQKFMSASTVVGETCKARQDVGTAVTWYYNQQKQGFESVIYRSSTRHTGVPIYWASRFSGSSGTDFTLTT DSLQTLTIEDLADYFCQQYGYSSWGAGGGAGTKLVLK (SEQ ID NO. 5).

[0051] IFA usability testing of monoclonal antibodies

[0052] PK15 cells were inoculated into a 24-well plate with a slide. When the cell density grew to about 70%, PRVHN-1201 was used to infect the cells at an MOI of 0.01. A negative control (PK15 cells not infected with the virus) was set up at the same time. After culturing in an incubator for 16 hours, the cell supernatant was discarded. Fix the cells with 4% PFA solution at room temperature for 30 minutes; permeabilize the cell membrane with 0.1% Triton X-100 at room temperature for 10 minutes; use 10% FBS PBS blocking solution at room temperature for 1 hour; use PR31 antibody diluted 1:500 as the primary antibody and FITC-labeled goat anti-mouse antibody as the secondary antibody, incubate at room temperature for 1 hour each; use DAPI nuclear staining solution at room temperature in the dark for 10 minutes, then wash 3 times with l×PBS and ddH20 respectively, and finally add a sealing tablet to prepare the slices. After drying, observe the results under a fluorescence microscope. The results showed that the detection titer of the PR31 antibody obtained by the present application screening was 2 -14 , which can fully meet the needs of PRV detection in samples.

[0053] In vitro neutralization activity assay of monoclonal antibodies

[0054] PK15 cells were evenly plated in a 96-well plate and used when the cell density reached about 60%. First, PRVHN-1201 virus was diluted to 200 TCID in DMEM. 50 / 100μL; then use DMEM to dilute the purified monoclonal antibody in multiple ratios. After the virus and antibody dilution is completed, different concentrations of antibodies are mixed with the diluted virus in equal volumes, and then incubated at 37℃ for 1 hour. Discard the PK-15 cell culture medium in the 96-well plate, wash off the residual culture medium with 1 PBS, then add 100μL / well of the prepared mixture, put it in the incubator for 1 hour, replace the cell maintenance solution, observe the cell lesion in real time, record the number of cell lesion wells, and analyze the antibody neutralization titer. However, the final results show that the monoclonal antibody obtained does not have a virus neutralizing effect and can only be used for the detection of PRV virus, but not for the prevention and treatment of PRV virus.

[0055] Monoclonal antibody specificity characterization

[0056] Different PRV virus strains (PRVHN-1201, PRVQXX, Bartha-K61 strain of the classic pseudorabies attenuated vaccine ("Weibining", gE gene naturally deleted, produced by Nanjing Tianbang)) were inoculated into PK15 cells, and negative controls (uninoculated cells) were set up and cultured in an incubator for 16 hours. Then the cells were fixed with 4% PFA and acted at room temperature for 30 minutes; blocked with 10% FBS PBS and acted at room temperature for 1 hour; monoclonal cell supernatant was used as the primary antibody and acted at room temperature for 2 hours; FITC-labeled goat anti-mouse antibody was used as the secondary antibody and acted at room temperature for 2 hours; after washing with 1×PBS, the results were observed under a fluorescence microscope. The results showed that the antibody of the present application could recognize the PRV virus strain, but did not produce a specific reaction to the vaccine strain with gE gene deletion.

[0057] Cross-reactivity of monoclonal antibodies

[0058] PK15 cells, Marcl45 cells and Vero cells were evenly spread on 24-well plates, and the virus was inoculated when the cell density reached 70%. PK15 cells were inoculated with PRVHN-1201 isolate, porcine circovirus (PCV-2) and porcine parvovirus (PPV); Marcl45 cells were inoculated with porcine reproductive and respiratory syndrome virus (PRRSV); Vero cells were inoculated with porcine epidemic diarrhea virus (PEDV), and PR31 monoclonal antibody was used as the primary antibody, and FITC-labeled goat anti-mouse antibody was used as the secondary antibody to detect the cross-reactivity of monoclonal antibodies. The results showed that the antibody of the present application can only specifically recognize PRV, and does not cross-react with other common PRRSV and PCV epidemic strains.

[0059] Example 2 Detection of Pseudorabies Virus in Tibetan Pig Semen

[0060] Experimental animals and experimental location: The experimental Tibetan pigs are 6 healthy boars aged 3 to 5 years. The experimental time is May to July 2024, and the location is the College of Animal Science of Tibet Agricultural and Animal Husbandry College.

[0061] Semen collection The Tibetan pig semen used in this experiment came from the internship base of Tibet Agricultural and Animal Husbandry College. The semen of healthy Tibetan pigs was collected by hand-holding method, and the middle semen was taken and filtered through 3 layers of gauze. The semen with sperm motility above 80% was diluted isothermally at 1:1 with sperm washing solution (based on 1L system, Tris 30g, citric acid 10g, glucose 12g, cysteine ​​6mM) and then put into a thermos bottle and immediately transported back to the laboratory. The collected boar semen was stored at -20℃ for future use.

[0062] Establishment of ELISA method for detecting PRV in semen of Tibetan pigs

[0063] Coating ELISA plate: Dilute PRV-gE protein to a concentration of 0.5 μg / mL with CBS buffer (0.05M carbonate-bicarbonate buffer, pH 9.6), take 100 μL to coat 96-well ELISA plate, and coat overnight at 4°C. Take out the next day and wash the plate 3 times with PBST, 3 minutes each time. Use 1% BSA prepared with PBST solution as blocking solution, add 100 μL of blocking solution to each well, and block at 37°C for 1 hour. After blocking, wash the plate 3 times with PBST, 3 minutes each time. Put it into a special packaging bag for 96-well ELISA plate, seal it with a sealing machine, and store it at 4°C.

[0064] Enzyme-labeled secondary antibodies were purchased from Beijing Solebao Technology Co., Ltd.

[0065] Sperm washing solution (based on 1L system, Tris 25-35g, citric acid 11-8g, glucose 8-15g, cysteine ​​3-8mM);

[0066] Washing solution (25×PBST): NaCl 100.0 g, KCl 0.2 g, MgCl2·6H2O 2.5 g, KH2PO4 5.0 g, Na2HPO4 28.5 g, Tween-20 12.5 mL, thimerosal 2.5 g, dilute to 1000 mL with distilled water, add 0.02% sodium azide as a preservative, sterilize and filter, then dispense;

[0067] Blocking solution (1% BSA): 1.0 g bovine serum albumin dissolved in 100 mL washing solution;

[0068] TMB colorimetric solution;

[0069] Stop solution: Take 54.3mL of 95% concentrated sulfuric acid and add distilled water to 1000mL;

[0070] Positive control: Tibetan pig PRV positive serum;

[0071] Negative control: Weigh an appropriate amount of BSA and dissolve it in PBS solution to a concentration of 2 μg / mL. Add 1000 IU of penicillin and streptomycin per milliliter, filter through bacteria removal, and powder it to be used as a positive control.

[0072] Specific detection method:

[0073] (3) Perform serial two-fold dilutions of the pretreated semen, add 100 μL per well to the pre-coated enzyme-linked immunosorbent assay (ELISA) plate, set up negative and positive controls, incubate at 37 °C for 30 minutes, discard the solution in the wells of the plate, wash the plate 3 times with the washing solution, 200 μL per well, let it stand for 3 minutes each time and then discard, and finally pat dry on absorbent paper;

[0074] (4) Add the PR31 monoclonal antibody diluted 1:1000 (0.01 M PBS, pH 7.2), incubate at 37 °C for 1 h, and wash the plate 5 times with PBST buffer;

[0075] (3) Add enzyme-labeled secondary antibody: Add the HRP-labeled goat anti-mouse IgG diluted 1:40000 (diluent is 0.01 M PBS pH 7.2) to the ELISA plate, 100 μL per well, incubate at 37 °C for 1 h. Wash the plate 5 times with PBST buffer;

[0076] (4) Develop color with TMB chromogenic solution in the dark, 100 μL per well, mix well, develop color in the dark at room temperature for 10 minutes, add one drop (50 μL) of 2 M sulfuric acid to each well to terminate the reaction, and read the absorbance value at 450 nm on the microplate reader within 15 minutes. Read the OD450 value;

[0077] (5) Determine the result: Blocking rate (BP) = (OD450 of negative control - OD450 of sample) / (OD450 of negative control - OD450 of positive control) × 100%; The detection method is valid when the OD450 of the positive control is less than 0.2 and the OD450 of the negative control is greater than 2.0; When BP ≤ 45%, the result is negative; When BP ≥ 50%, the result is positive; When 45% < BP < 50%, the result is suspicious. The results show that the semen of Tibetan pigs positive for PRV can still be detected after being diluted 1:16, indicating that the PRV competitive ELISA detection method for Tibetan pig semen established using the PR31 monoclonal antibody of this application has good sensitivity.

[0078] Coincidence rate experiment

[0079] Use the competitive ELISA experimental method established in this example to detect 8 samples of PRV-positive Tibetan pig semen and 12 samples of PRV-negative Tibetan pig semen stored in this laboratory. The results show that the coincidence rate of the results of the PRV competitive ELISA detection method for Tibetan pig semen established using the PR31 monoclonal antibody of this application reaches 100%.

[0080] Clinical stability experiment

[0081] The test kits to be tested were randomly selected from the same batch and divided into two parts. One part was placed in a 4°C refrigerator, and the other was placed in a 37°C constant temperature box. After 15 days, they were taken out and placed in a 4°C refrigerator for equilibrium overnight. The stability test was performed with a positive quality control product. The test results of the two were the same, confirming that the test kit of the present application has good stability.

[0082] The above description of the embodiments is to facilitate the understanding and use of the present invention by those skilled in the art. It is obvious that those skilled in the art can easily make various modifications to these embodiments and apply the general principles described herein to other embodiments without creative work. Therefore, the present invention is not limited to the above embodiments. Improvements and modifications made by those skilled in the art based on the principles of the present invention without departing from the scope of the present invention should be within the protection scope of the present invention.

Claims

1. A monoclonal antibody PR31 that specifically recognizes pseudorabies virus, characterized in that: The amino acid sequence of the heavy chain variable region of the monoclonal antibody PR31 is as shown in SEQ ID NO: 4 in the sequence listing, and the amino acid sequence of the light chain variable region is as shown in SEQ ID NO: 5 in the sequence listing.

2. A product for detecting pseudorabies virus in a sample, characterized in that: The product includes the monoclonal antibody PR31 described in claim 1. Preferably, the sample is a semen sample of Tibetan pigs.

3. The product according to claim 2, characterized in that The product is an ELISA detection kit, and the kit includes a coated enzyme-linked immunosorbent assay (ELISA) plate, a blocking solution, a sperm washing solution, an enzyme-labeled secondary antibody, a washing solution, a chromogenic agent, and a termination solution.

4. The product according to claim 3, wherein the composition of the sperm washing solution is: based on a 1 L system, 25 - 35 g of Tris, 8 - 11 g of citric acid, 8 - 15 g of glucose, and 3 - 8 mM of cysteine.

5. The application of the monoclonal antibody PR31 described in claim 1, and / or the product described in any one of claims 2 - 4 in the preparation of a detection product for detecting PRV in the semen of Tibetan pigs.

6. A method for detecting PRV in Tibetan pig semen for non-disease diagnosis and treatment purposes, characterized in that The method includes the following steps: (1) Add 100 μL of the pretreated semen to each well of the pre-prepared coated ELISA plate, set negative and positive controls, incubate at 37 °C for 30 minutes, discard the solution in the wells of the plate, wash the plate 3 times with the washing solution, 200 μL per well, let it stand for 3 minutes each time and then pour it out, and finally pat it dry on the absorbent paper; (2) Add the monoclonal antibody PR31 described in claim 1 diluted 1:1000 (0.01 M PBS, pH 7.2), incubate at 37 °C for 1 h, and wash the plate 5 times with PBST buffer; (3) Add the enzyme-labeled secondary antibody: Add HRP-labeled goat anti-mouse IgG diluted 1:40000 (the diluent is 0.01 M PBS pH 7.2) to the ELISA plate, 100 μL per well, incubate at 37 °C for 1 h. Wash the plate 5 times with PBST buffer; (4) Develop color with TMB chromogenic solution in the dark, 100 μL per well, mix well, develop color in the dark at room temperature for 10 minutes, add one drop (50 μL) of 2 M sulfuric acid to each well to terminate the reaction, and read the absorbance value at 450 nm on the microplate reader within 15 minutes. Read the OD450 value; (5) Determine the result: Blocking rate (BP) = (negative control OD450 - sample OD450) / (negative control OD450 - positive control OD450) × 100%; the detection method is valid when the positive control is less than 0.2 and the negative control is greater than 2.0; when BP ≤ 45%, the result is negative; when BP ≥ 50%, the result is positive; when 45% < BP < 50%, the result is suspicious.

Citation Information

Patent Citations

  • Enzyme linked immunosorbent assay kit for porcine pseudorabies virus gE protein antibody and application thereof

    CN102608315A

  • Swine pseudorabies virus and vaccine composition as well as preparation method and application thereof

    CN104004774A

  • Competitive ELISA detection kit for porcine pseudorabies virus gE protein antibody, and detection method thereof

    CN107831309A

Cited By

  • PRRSV monoclonal antibody and Tibetan pig semen ELISA detection kit thereof

    CN120248104A

  • Rabbit monoclonal antibody of anti-pseudorabies virus glycoprotein gE and application of rabbit monoclonal antibody in immunodetection

    CN121824743A